Literature DB >> 11230513

Characterisation of L-tryptophan transporters in human placenta: a comparison of brush border and basal membrane vesicles.

Y Kudo1, C A Boyd.   

Abstract

The mechanisms responsible for L-tryptophan transport at both the maternal- and fetal-facing surfaces of the term placenta have been determined in isolated membrane vesicles as part of a study on placental indoleamine 2,3-dioxygenase, the L-tryptophan-catabolising enzyme recently shown to regulate feto-maternal immunology. Brush border vesicle uptake of L-tryptophan is substantially into an osmotically active space. It is sodium independent and N-ethylmaleimide sensitive. Uptake of L-tryptophan, which is markedly stereospecific, has a Km of 26.3 microM and Vmax of 1.72 pmol (mg protein)(-1) s(-1) and is completely abolished by the L-system-specific substrate 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid (BCH). These findings are in keeping with L-tryptophan transport being exclusively via system L (induced by the heterodimeric heavy chain of CD98 and system L-amino acid transporter-1 (LAT-1)). 1-Methyl-tryptophan (which is a known competitive inhibitor of indoleamine 2,3-dioxygenase) is a competitive inhibitor of L-tryptophan flux through this transport system (Ki = 113 microM). Basal membrane transport of L-tryptophan is more complex. Uptake is slower than at the brush border and although, as in the brush border, uptake is sodium independent, it is less sensitive to N-ethylmaleimide. There is clear evidence that two systems contribute to basal membrane transport since BCH is (in sodium-free media) only a partial inhibitor whereas L-histidine and L-cysteine are fully effective. The simplest explanation of these and other findings is that the basal membrane possesses two systems, one of which is similar to that induced by the heavy chain of CD98 and system L-amino acid transporter-2 (LAT-2). The other appears to be system y+L since in the presence of BCH inhibition by L-leucine but not by L-lysine is sodium dependent. These findings suggest the existence of non-identical carrier-mediated transport systems for L-tryptophan in brush border and basal membranes. This asymmetry may explain net transplacental transfer of this amino acid.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11230513      PMCID: PMC2278476          DOI: 10.1111/j.1469-7793.2001.0405i.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  21 in total

1.  Development and polarization of cationic amino acid transporters and regulators in the human placenta.

Authors:  P T Ayuk; C P Sibley; P Donnai; S D'Souza; J D Glazier
Journal:  Am J Physiol Cell Physiol       Date:  2000-06       Impact factor: 4.249

2.  Heterodimeric amino acid transporters: expression of heavy but not light chains of CD98 correlates with induction of amino acid transport systems in human placental trophoblast.

Authors:  Y Kudo; C A Boyd
Journal:  J Physiol       Date:  2000-02-15       Impact factor: 5.182

Review 3.  Surface antigen CD98(4F2): not a single membrane protein, but a family of proteins with multiple functions.

Authors:  R Devés; C A Boyd
Journal:  J Membr Biol       Date:  2000-02-01       Impact factor: 1.843

4.  Cloning and functional characterization of a Na(+)-independent, broad-specific neutral amino acid transporter from mammalian intestine.

Authors:  D P Rajan; R Kekuda; W Huang; L D Devoe; F H Leibach; P D Prasad; V Ganapathy
Journal:  Biochim Biophys Acta       Date:  2000-01-15

5.  The role of L-tryptophan transport in L-tryptophan degradation by indoleamine 2,3-dioxygenase in human placental explants.

Authors:  Y Kudo; C A Boyd
Journal:  J Physiol       Date:  2001-03-01       Impact factor: 5.182

6.  A bicyclic amino acid to improve discriminations among transport systems.

Authors:  H N Christensen; M E Handlogten; I Lam; H S Tager; R Zand
Journal:  J Biol Chem       Date:  1969-03-25       Impact factor: 5.157

7.  LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine.

Authors:  G Rossier; C Meier; C Bauch; V Summa; B Sordat; F Verrey; L C Kühn
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

8.  Isolation and partial characterization of the basal cell membrane of human placental trophoblast.

Authors:  L K Kelley; C H Smith; B F King
Journal:  Biochim Biophys Acta       Date:  1983-09-21

Review 9.  Exploiting amino acid structure to learn about membrane transport.

Authors:  H N Christensen
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1979

10.  Human placental indoleamine 2,3-dioxygenase: cellular localization and characterization of an enzyme preventing fetal rejection.

Authors:  Y Kudo; C A Boyd
Journal:  Biochim Biophys Acta       Date:  2000-01-03
View more
  39 in total

1.  Activation of system L heterodimeric amino acid exchangers by intracellular substrates.

Authors:  Christian Meier; Zorica Ristic; Stefan Klauser; François Verrey
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

2.  Homocysteine transport by systems L, A and y+L across the microvillous plasma membrane of human placenta.

Authors:  Eleni Tsitsiou; Colin P Sibley; Stephen W D'Souza; Otilia Catanescu; Donald W Jacobsen; Jocelyn D Glazier
Journal:  J Physiol       Date:  2009-06-29       Impact factor: 5.182

Review 3.  Amino acid catabolism: a pivotal regulator of innate and adaptive immunity.

Authors:  Tracy L McGaha; Lei Huang; Henrique Lemos; Richard Metz; Mario Mautino; George C Prendergast; Andrew L Mellor
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

4.  The role of L-tryptophan transport in L-tryptophan degradation by indoleamine 2,3-dioxygenase in human placental explants.

Authors:  Y Kudo; C A Boyd
Journal:  J Physiol       Date:  2001-03-01       Impact factor: 5.182

Review 5.  The role of placental nutrient sensing in maternal-fetal resource allocation.

Authors:  Paula Díaz; Theresa L Powell; Thomas Jansson
Journal:  Biol Reprod       Date:  2014-08-13       Impact factor: 4.285

6.  Decreased IDO activity and increased TTS expression break immune tolerance in patients with immune thrombocytopenia.

Authors:  Chun-Yan Wang; Yan Shi; Ya-Nan Min; Xiao-Juan Zhu; Cheng-Shan Guo; Jun Peng; Xiao-Yuan Dong; Ping Qin; Jian-Zhi Sun; Ming Hou
Journal:  J Clin Immunol       Date:  2011-04-13       Impact factor: 8.317

7.  Placental and fetal disposition of mercuric ions in rats exposed to methylmercury: role of Mrp2.

Authors:  Christy C Bridges; Lucy Joshee; Rudolfs K Zalups
Journal:  Reprod Toxicol       Date:  2012-10-08       Impact factor: 3.143

8.  IDO induces expression of a novel tryptophan transporter in mouse and human tumor cells.

Authors:  Jonathan D Silk; Samira Lakhal; Robert Laynes; Laura Vallius; Ioannis Karydis; Cornelius Marcea; C A Richard Boyd; Vincenzo Cerundolo
Journal:  J Immunol       Date:  2011-07-08       Impact factor: 5.422

Review 9.  Trial watch: IDO inhibitors in cancer therapy.

Authors:  Erika Vacchelli; Fernando Aranda; Alexander Eggermont; Catherine Sautès-Fridman; Eric Tartour; Eugene P Kennedy; Michael Platten; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-12-15       Impact factor: 8.110

10.  Combined effect of antiretroviral therapy and blockade of IDO in SIV-infected rhesus macaques.

Authors:  Adriano Boasso; Monica Vaccari; Dietmar Fuchs; Andrew W Hardy; Wen-Po Tsai; Elzbieta Tryniszewska; Gene M Shearer; Genoveffa Franchini
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.